American Association for Cancer Research (AACR)

Award Recipients Announced for the 2025 San Antonio Breast Cancer Symposium Ben Ho Park, MD, PhD, and Sara M. Tolaney, MD, MPH, will be honored with awards at the 2025 San Antonio Breast Cancer Symposium.

The AACR congratulates Ben Ho Park, MD, PhD, recipient of the 2025 AACR Distinguished Lectureship in Breast Cancer Research, and Sara M. Tolaney, MD, MPH, recipient of the 2025 AACR Outstanding Investigator Award for Breast Cancer Research. #SABCS25

Submit an abstract by December 8 for the AACR Special Conference on RAS Oncogenesis and Therapeutics (March 5-8, 2026; Los Angeles), chaired by Andrew J. Aguirre, Channing J. Der, David S. Hong, and Kevan M. Shokat. Learn more:
buff.ly/KSYsLWC
#AACRras26

Evolution Under Therapy: Resistance Mechanisms—
Andrew J. Aguirre, Nathan E. Reticker-Flynn, Susan M. Rosenberg, and Kathleen Burkhardt addressed this topic in a plenary session at the AACR Special Conference on Cancer Evolution.
#AACRevol25 @retickerflynn.bsky.social

#AACRevol25 cochair Mara H. Sherman welcomed attendees to the AACR Conference on Cancer Evolution this evening in Albuquerque. The conference will explore how evolutionary principles underlie cancer initiation, progression, treatment resistance, metastasis, and relapse. @marasherman.bsky.social

The inaugural AACR #PediatricCancerProgressReport details how research advances have led to over 30 new treatments for pediatric cancers in the last decade, while also highlighting the gaps in care that still exist. Check out highlights from the report on the #AACRBlog: buff.ly/KnmJUIo

Thank you to everyone who participated in the inaugural release of the AACR #PediatricCancerProgressReport, especially the survivors who shared their stories, the Steering Committee, and all those who joined in person and virtually. Read the Report: buff.ly/Jyf8dwI

Capital Police Officer and Childhood Brain Cancer Survivor, Marquis Gomez, stopped by the AACR #PediatricCancerProgressReport briefing to chat with some of the survivors highlighted in the report. buff.ly/Jyf8dwI

Capital Police Officer and Childhood Brain Cancer Survivor, Marquis Gomez, stopped by the AACR #PediatricCancerProgressReport briefing to chat with some of the survivors highlighted in the report.

Acute myeloid lymphoma survivor Tyler Peryea and his mother, Jamie Penkower, speak about how federal funding for childhood cancer research not only gives hope to kids but is an investment in our future. Read his story: buff.ly/LEM8mFO #PediatricCancerProgressReport

Diane Owens, mother of Neurofibromatosis Type 1 survivor Alex Owens, explains the importance of health literacy, patient advocacy, and how research is giving her son back his childhood. Read Alex's story in the AACR #PediatricCancerProgressReport. buff.ly/3aXsuOd

Brain cancer survivor Chenia Lloyd-Gascho discussed what living with cancer means as a young adult and the importance of research. Read his story in the AACR #PediatricCancerProgressReport 2025. buff.ly/k4nB17q

"Research gives families hope. On the hard days, all you have is hope." Adrian Horn, mother of acute lymphoblastic leukemia survivor Lianna Munir, candidly shares their family's journey. Read Lianna's story in the AACR #PediatricCancerProgressReport 2025. buff.ly/6NEC2Qs

NCI Director Dr. Anthony Letai speaks about the gaps in progress for certain cancers outlined in the AACR Pediatric Cancer Progress Report and the NCI's commitment to close those gaps. Read the newly released #PediatricCancerProgressReport. buff.ly/Jyf8dwI

Dr. Kimberly Stegmaier of @danafarber.bsky.social, cochair of the AACR Pediatric Cancer Progress Report Steering Committee, discusses the mission to minimize the lifelong impact of cancer treatment on children highlighted in the inaugural #PediatricCancerProgressReport.

Dr. Elaine Mardis, cochair of the AACR Pediatric Cancer Progress Report Steering Committee, explains the uniqueness of childhood cancer and the importance of dedicated federal funding, as highlighted in the inaugural #PediatricCancerProgressReport. cancerprogressreport.aacr.org/pediatric/

Representative McCaul, co-chair and founder of the Childhood Cancer Caucus, joins the #PedatricCancerProgressReport Briefing to speak about how childhood cancer impacted his life and the exciting progress being made. Thank you, Rep. McCaul, for your continued support of cancer research.

AACR CEO Margaret Foti, PhD, MD (hc), welcomes attendees to today's release of the inaugural AACR Pediatric Cancer Progress Report.
#CancerResearchSavesLives® #PediatricCancerProgressReport

The AACR #PediatricCancerProgressReport 2025 is now available online. The report details research-driven advances in the prevention, detection, and treatment of pediatric cancer. Learn more: cancerprogressreport.aacr.org/pediatric/

Chronic Lymphocytic Leukemia Overview - American Association for Cancer Research (AACR) Chronic lymphocytic leukemia (CLL) is a common type of leukemia in adults and often occurs during or after middle age. Learn about treatment options for this cancer.

Chronic lymphocytic leukemia is one of the most common types of leukemia in adults. Learn more about this form of leukemia and potential treatment options: buff.ly/q4Xa32i

FDA grants traditional approval to pirtobrutinib for chronic lymphocyt On December 3, 2025, the Food and Drug Administration granted traditional approval to pirtobrutinib (Jaypirca, Eli Lilly and Company) for adults with relapsed o

The @fda.gov granted traditional approval to the BTK inhibitor pirtobrutinib for certain previously treated adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: buff.ly/rHyJoSQ

What happens when a life in media, advocacy, and leadership converges on a mission to transform the way we support people with cancer? On this episode of Believe in Progress, an AACR Foundation… 060: Reimagining Cancer Survivorship and Leading with Heart: Suzanne Stone

On this episode of Believe in Progress, Mitch talks with Suzanne Stone, Emmy winner and President & CEO of Livestrong, to discuss the organization’s legacy, its future, and her mission to strengthen support for people with cancer. Listen here: buff.ly/RQWRNaG

Submit an abstract by December 4 for the AACR Special Conference on Innovations in Kidney Cancer Research (March 13-16, 2026; Philadelphia), chaired by Eric Jonasch, M. Celeste Simon, Samra Turajlic, and Qing Zhang. Learn more:
buff.ly/IoqbeGk
#AACRkidney26 @turajliclab.bsky.social

There's still time to make a #GivingTuesday donation to the @AACR that will fund the future of cancer research. buff.ly/AMNj32J #CancerResearchSavesLives® #AACRGrants

This #GivingTuesday, your donation to the AACR will fund the future of cancer research. Your support today will drive progress against cancer tomorrow. Donate now: buff.ly/AMNj32J to help advance cancer science and medicine. #CancerResearchSavesLives®

Cut Back on Butter | Cancer Today Substituting butter with an equal amount of plant-based oil was associated with a 17% reduction in cancer mortality risk.

In the latest issue of Cancer Today: Plant-based oils offer a healthier alternative to butter. Learn how these ingredients can impact your cancer mortality risk. www.cancertodaymag.org/fall-2025/cu...

Register by Dec 15 to get the lowest rates for the AACR Special Conference on Innovations in Prostate Cancer Research and Treatment (Jan 20-22; Boston), chaired by Peter Nelson, Elena Castro, Patrick Pilié, and Eliezer Van Allen. Learn more:
buff.ly/EXiV4Yr
#AACRprostate26 @vanallenlab.bsky.social

Fund the Future of Cancer Research: Your donation to the @AACR today supports grants for early-career cancer researchers. buff.ly/AMNj32J #CancerResearchSavesLives® #GivingTuesday #AACRGrants

#AACRGrants propel progress in cancer research. Your #GivingTuesday gift to the AACR today, advances lifesaving science. buff.ly/5CKT5rZ
#CancerResearchSavesLives®

Today and every day, we are grateful for the dedication of all those working to advance lifesaving cancer research. Happy Thanksgiving.

Among the studies highlighted by the editors of AACR’s journals in November were sucralose’s effect on immunotherapy and a gene signature predictive of CAR T-cell therapy response. Learn more on the #AACRBlog: buff.ly/82t95Sc
@aacrjournals.bsky.social